3D Bioprinting Market Research Report – forecast till 2028

3D Bioprinting Market Research Report: By Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting), By Material (Living Cells, Hydrogels, Extracellular Matrices), By Application (Research Applications, Clinical Applications), By End-user (Pharmaceutical & Biotechnology Companies, Research Organizations & Academic Institutes) - Forecast till 2028

ID: MRFR/MED/0367-CR | February 2021 | Region: Global | 163 pages

3D Bioprinting Market Overview


3D Bioprinting Market share is projected to touch a value of USD 4.3 Billion by 2028, states Market Research Future (MRFR) in its report. The 3D Bioprinting market can display a CAGR of 15.5% during the forecast period due to its growing applications in tissue engineering and organ transplantation.


3D bioprinting encompasses an array of 3D printing methods to combine cells and biomaterials to produce biomedical parts. Although the technology is in high use for research and development purposes, its application in the production of tissues and organs is likely to garner high demand.


The prevailing pandemic, COVID-19, has generated the demand for companies to maintain a digital asset. In situations like these, the 3D printer aids to meet the requirement, which is expected to boost the 3D bioprinting market growth.


Market Dynamics


The cost-economical nature of 3D bioprinting is expected to brighten the bioprinting future. This is buttressed by the use of small implants and prosthetics used in the treatment of dental or craniofacial disorders. Furthermore, the presence of numerous players in the 3D bioprinting market can keep production costs low and augur well for the market in the forthcoming years.


However, lack of awareness of the technology and shortage of skilled professionals can act as growth deterrents in the 3D Bioprinting market.


Drivers


Growing Demand for Organ Transplantation to Boost the Market


Growing demand for organ transplantation is projected to drive the 3D Bioprinting market by 2023.  The rising investments in 3D bioprinting via public and private means to widen its scope is likely to boost the 3D Bioprinting market growth. Moreover, the cost-effectiveness of 3D bioprinted products is expected to develop the industry in the forecast timeframe.


Opportunities


Growing Application of 3D Bioprinting in Cosmetic Industry to Offer Lucrative Opportunities


The extensive usage of 3D bioprinting in the cosmetic industry is expected to offer various growth opportunities to the key players. The growing R&D, partnerships, and acquisitions are likely to augment the market in the coming period.


Restraints


Lack of Expertise to Hinder Market Growth


One of the major factors hindering the 3D Bioprinting market growth is the lack of expertise and awareness is expected to obstruct the market growth during the forecast period.


Challenges


Socioethical Concerns Due to the usage of 3D Bioprinted products


The application of bioprinted products inside human bodies can grow biosafety concerns, which may also question some religious beliefs that can hinder the 3D Bioprinting market growth. In addition, the concerns associated with waste elimination is expected to further restrict the 3D Bioprinting market growth.


Cumulative Growth Analysis


Market is Expected to Grow Significantly in the Forecast Period


The 3D Bioprinting market is anticipated to grow significantly in the coming period, at a rapid pace. The on-going technical development, the growing awareness, and the increasing 3D bioprinting applications are predicted to underpin the trade expansion at a global front.


Market Segmentation


The 3D bioprinting market is segmented by technology, material, application, and end-user.


By Technology


Inkjet 3D Bioprinting Segment to Exhibit Higher CAGR


Based on technology, the global 3D bioprinting market is segmented into inkjet 3D bioprinting, microextrusion bioprinting, magnetic 3D bioprinting, and laser-assisted bioprinting. Among all, the microextrusion bioprinting segment is projected to witness a CAGR of 25.24% during the forecast period. This can be attributed to its growing applications in bioprinting. On the other hand, inkjet 3D bioprinting can exhibit 26.44% CAGR owing to being a viable alternative for scaffold fabrication.


By Material


By material, the global 3D bioprinting market is segmented into living cells, extracellular matrices, and hydrogels. The hydrogels segment is expected to generate USD 652.54 million during the forecast period at a CAGR of 26.63% 


By Applications


Research Applications Segment to Exhibit Higher CAGR due to its Growing Application in Regenerative Medicines


Based on applications, the 3D Bioprinting market is segmented into research and clinical applications. The research applications segment is expected to exhibit a  CAGR of 24.74% by during the forecast period owing to applications in 3D cell culture and regenerative medicine. The clinical applications segment is likely to hold the market value of USD 507.55 million during the forecast period while expanding at a CAGR of 24.19% during the assessment period.


By End-Users


Pharmaceutical & Biotechnology Segment to Grow Due to Growing Demand for Personalized Medicines


Among end-users, the 3D bioprinting market is segmented into pharmaceutical & biotechnology companies and research organizations & academic institutes. Pharmaceutical & biotechnology companies are projected to display a CAGR of 24.98% till 2023 owing to the trend in personalized medicines.


Regional Analysis


North America is expected to hold the Largest Market Share in the Global 3D Bioprinting Market


As per the 3D bioprinting industry analysis conducted by MRFR, the Americas is expected to acquire the market value of USD 689.91 million during the forecast period.This can be attributed to growing investments in research and development and the presence of advanced healthcare infrastructure. The demand for organ transplant is likely to rise to grow the regional market in the coming period. In addition, the on-going development of 3D printed pills, which can be customized as per the person’s age and body weight, is expected to offer various opportunities for expansion for the 3D bioprinting market.


The APAC is projected to acquire the market value of USD 507.18 million during the forecast period at a CAGR of 27.25% . The APAC region is anticipated to grow at a rapid pace due to the development in 3D printing, incorporation of the latest technologies in the healthcare sector, and abundance of opportunities. In addition, increasing government funding to accelerate the pace of 3D printing technology is projected to augment the 3D bioprinting market size.


The Europe 3D bioprinting market is expected to acquire a market value of USD 649.91 million during the forecast period due to the rising focus on health and wellness. Increased demand for cosmetic surgery can play a salient role in the market’s progress in the region. Furthermore, agreements between established players to expedite the evolution of technology can net novel results. This is exemplified by the deal signed between BASF SE and Poietis to improve skincare products by the former.


Competitive Landscape


Growing Initiatives to Expand Customer Base to Grow Competition


The growing collaboration and rising partnerships among key players is expected to strengthen the competitiveness of the 3D bioprinting market. The renowned players of the market are taking initiatives to grow their consumer base by incorporating innovation in their products.


Industry News


November 2020


Professor of Biomedical Engineering Adam Feinberg and his team have built the first-ever full-size 3D bioprinted human heart model with the usage of Freeform Reversible Embedding of Suspended Hydrogels (FRESH) technique. 


Key Players



  • REGENHU Ltd. (Switzerland)

  • Nano3D Biosciences Inc. (U.S.)

  • FUJIFILM Wako Automation Corporation (U.S.)

  • Organovo Holdings Inc. (U.S.)

  • Allevi (U.S.)

  • Regenovo Biotechnology Co. Ltd. (China)

  • Stratasys Ltd. (U.S.)

  • Aspect Biosystems Ltd. (Canada)

  • Poietis (France)

  • EnvisionTEC GmbH (Germany)

  • Cellink AB (Sweden)

  • Cyfuse Biomedical K.K. (Japan)


Report Overview


The 3D bioprinting market is expected to expand significantly during the forecast period owing to the rapid advancement in healthcare.



Report Scope:
Report Attribute/Metric Details
  Market Size   2028: USD 4.3 Billion
  CAGR   15.5% (2021-2028)
  Base Year   2019
  Forecast Period   2020-2028
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Technology, Material, Application, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), Organovo Holdings Inc. (U.S.), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Stratasys Ltd. (U.S.), Aspect Biosystems Ltd. (Canada), Poietis (France), EnvisionTEC GmbH (Germany), Cellink AB (Sweden), Cyfuse Biomedical K.K. (Japan)
  Key Market Opportunities   Growing Application of 3D Bioprinting in Cosmetic Industry
  Key Market Drivers   Growing Demand for Organ Transplantation


Frequently Asked Questions (FAQ) :


3D bioprinting encompasses an array of 3D printing methods to combine cells and biomaterials to produce biomedical parts. Although the technology is in high use for research and development purposes, its application in the production of tissues and organs is likely to garner high demand.

The 3D Bioprinting Market is predicted to touch USD 4.3 Billion by 2028.

The 3D Bioprinting Market is projected to grow at a 15.5% CAGR between 2021-2028.

The Americas are projected to have a major share in the 3D Bioprinting Market.

Growing demand for organ transplantation is Boosting Market growth.

Lack of skilled professionals and lack of awareness may limit market growth.